Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON31397Not yet recruiting
Open-label trial of sodium oxybate in narcolepsy (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Difference in energy expenditure between narcolepsy patients and healthy controls, Difference in insulin sensitivity between narcolepsy patients and healthy controls and 1 more. Planned start Jan 2008; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON31397.